Skip to main content
. 2013 Dec 5;6:508. doi: 10.1186/1756-0500-6-508

Figure 2.

Figure 2

Response of liver metastases to CPT-11-cetuximab. After 13 courses of chemotherapy with irinotecan and cetuximab (CPT-11 + C-mab), blood levels of CEA and CA19-9 dropped to 14.3 ng/mL and 16.8 U/mL, respectively, and liver metastases showed reduction, indicating partial response.